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A B S T R A C T
Netrins and semaphorins are known as neuronal guidance molecules that are important to the facilitate pat-
terning of the nervous system in embryonic development. In recent years, their function has been broadened to
guide development in other systems, including the vascular system, where netrins and semaphorins critically
contribute to the development of the vascular system. Evidence is accumulating that these guidance cues are also
of critical importance in the biology of the mature endothelium by regulating the maintenance of endothelial
quiescence. Here we review our current insights into the roles of netrins and semaphorins in endothelial cell
survival, self-renewing, barrier function, response to wall shear stress, and control of the vascular tone. We also
provide suggestions for future research into the functions of netrins and semaphorins in mature endothelial cell
biology.
1. Introduction
The vascular system involves an extensive network of arteries, ca-
pillaries and veins, lined by endothelial cells. While the endothelial
monolayer was ﬁrst thought to be an inert layer between blood and
tissue, a range of discoveries has led to better understanding of the
complex active homeostatic functions of the endothelium including the
controlling vascular tone, blood ﬂuidity, and vascular inﬂammation
[1]. The observation that the anatomy and gene expression patterns of
the vascular system of vertebrates often overlap with that of the ner-
vous system has led to the growing awareness that the coordinated
patterning of nerves and vessels is achieved by each system separately
using the same cues and signals [2,3]. These conserved patterning
factors, together called the “neuronal guidance cues” (NGCs), were ﬁrst
identiﬁed in neural development and involve 4 major families of con-
served ligands netrins, slits, semaphorins, and ephrins. NGCs act to-
gether through a complex interplay of short and long-range signals that
can either repel or attract the cells of the developing network [4]. The
eﬀects of NGCs on the developing vascular network, especially with
respect to angiogenesis, have been well characterized and received
some excellent reviews [5–9]. However, next to their function in de-
velopment, evidence is accumulating that a selective group of the
NGCs, the netrins and semaphorins, have important homeostatic func-
tions in the mature established endothelial monolayer. Here, we review
the novel insights into the regulatory roles of netrins and semaphorins
in endothelial cells in the mature endothelium.
2. Role of netrins and semaphorins in the survival of endothelial
cells
The integrity of the vascular endothelium depends on the continued
replacement of injured or senescent cells. Conditions that “stress” en-
dothelial cells, such as an adverse hemodynamic or metabolic en-
vironment, or local and systemic inﬂammation, are associated with a
faster turnover of endothelial cells [10,11]. This concept of endothelial
cell turnover naturally raises two questions: (1) what contributes to
preservation or survival of endothelial cells, and (2) what regulates the
renewal activity of endothelial cells? Recent evidence points at roles for
netrins and semaphorins in both phenomena.
Besides acting as a directional signal for angiogenic sprouting,
vascular endothelial growth factor (VEGF) is a survival factor that plays
a major role in the shaping of the vascular networks. Hypoxic tissues in
need of (neo-)vascularization express VEGF that supports the genera-
tion and survival of the endothelial cells that makeup the new angio-
genic network. However, this also relives the hypoxia in the tissue and,
therefore, other mechanisms have to kick in to replace the pro-survival
signals previously provided by VEGF. These stabilization signals in-
clude, amongst others, angiopoietin1/TIE2 signaling, platelet-derived
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growth factor (receptor signaling), and signaling generated by the in-
teraction of endothelial cells and extracellular matrix, more speciﬁcally
the endothelial basement membrane, via integrins. Integrin activity has
been shown to be important in stabilization and survival of mature
vascular networks [12]. These stabilization signals within a functional
network rely heavily on stimulation of endothelial cells by laminar
shear stress. Below we discuss recent studies that demonstrate promi-
nent roles for the netrins and semaphorins in the regulation of en-
dothelial cell survival.
2.1. NTN4 promotes endothelial cell survival by activating integrin α6β1
The ﬁrst vertebrate netrin was discovered in 1994 as a guidance cue
for the embryonic development of commissural axons in the spinal cord
[13,14]. Up until today, expression of six diﬀerent netrins has been
described in mammals. Netrin-1, 3, 4, and 5 (NTN1, 3, 4, 5) are secreted
proteins, while netrin-G1 and G2 (NTNG1 and G2) are membrane-
bound proteins tethered by glycosyl-phosphatidylinostitol tails [15,16].
Netrins can bind to the classical “deleted in colorectal cancer” (DCC),
neogenin (NEO1) and uncoordinated-5 (UNC-5) receptors. Beside the
classical ligand receptor interactions also interactions with other re-
ceptors, such as integrins [17] and adenosine A2b receptors
(ADORA2B) [18], have been described (Fig. 2). In human endothelial
cells, NTN4 is the highest expressed netrin class member [19–21]
(Fig. 1) and can be upregulated by laminar shear stress [22]. Interest-
ingly, NTN4 can serve as an activator of integrins, including endothelial
integrin α6β1, which can bind laminin [23–25]. In human micro-
vascular endothelial cells, NTN4 directly interacts with the integrin
α6β1 complex, leading to more activated integrin β1. Functionally, a
NTN4 coating indeed increases adhesion of endothelial cells in vitro to
culture plate [23]. Studies from multiple groups also show that the
presence of NTN4 increases activity of Akt and ERK1/2, suggesting that
NTN4 is able to induce survival signaling in endothelial cells [26,27]. In
line with this, less caspase3 activity was detected when human umbi-
lical vein endothelial cells (HUVECs) were treated with NTN4 [21,26].
Together, these results suggest that NTN4 may provide endothelial cells
with pro-survival signaling especially in stable functional vascular
networks. It is important to note that NTN4 knockout mice, under
normal conditions, do not have any defects in retina vascular networks
[28,29]. Therefore, to fully understand the in vivo function of NTN4,
further investigation is needed.
Intriguingly, NTN4 is itself a component of the basement membrane
[30]; this is not surprising as the netrin family is structurally related to
the laminin superfamily which has an important role in the structure of
the extracellular matrix [31]. As a component of the basement mem-
brane, NTN4 has been shown to regulate the assembly of laminin net-
works, thus altering the structure of the basement membrane and
thereby aﬀecting the survival of endothelial cells [32]. A report by
Reuten et al. demonstrated that NTN4 competitively binds to the la-
minin γ chain, causing disassembly of the laminin network and dis-
ruption of the endothelial basement membrane [32]. Adding NTN4 to
capillary networks in chick embryo chorioallantoic membranes dis-
rupted formation of stable capillary networks [32]. It was then
suggested that NTN4 causes destabilization of blood vessels. This sug-
gestion is at ﬁrst glance contradictory to the pro-survival role of NTN4.
However, in order to function as a laminin network disassembling
agent, a concentration of 2.1 μM NTN4 was needed, which is probably
hardly reached in physiological conditions. Generally, a concentration
of around 1.7 pM NTN4 can be found in endothelial cell culture [21].
Therefore, the consequences of regulation of the basement membrane
structure by NTN4 in the physiological concentration range are not
fully elucidated yet.
2.2. NTN1 has an anti-apoptotic eﬀect on endothelial cells
Next to NTN4, NTN1 was found to be expressed by various types of
endothelial cells. In general, NTN1 is believed to have moderate ex-
pression in endothelial cells [19,33,34]. Co-localization of NTN1 with
endothelium was observed in both large blood vessels and capillaries
[26,35]. There is a lack of agreement in the serum concentration NTN1.
In healthy humans, several picograms to several hundred picograms per
milliliter NTN1 were detected in serum using enzyme-linked im-
munosorbent assays, depending on the lab and reagents used [36–41].
More expression of NTN1 was found in endothelial cells cultured under
shear stress and in aortic regions with higher shear stress [34]. In tumor
cells and neurons, NTN1 has been shown to be a survival factor in cells
expressing the netrin receptors DCC and UNC5H [42,43]. In endothelial
cells, NTN1 also acts as a survival factor as NTN1 blocked the apoptotic
eﬀect of serum starvation in HUVECs and human umbilical artery en-
dothelial cells [44]. This anti-apoptotic eﬀect was proven to be an an-
tagonistic eﬀect of NTN1 binding to UNC5B, as blocking UNC5B with
siRNA also reduced apoptosis while abolishing the anti-apoptotic eﬀect
of NTN1 [44]. Further evidence also demonstrated that NTN1 promotes
endothelial cell survival by blocking the UNC5B-induced inhibition of
death-associated protein kinase 1 (DAPK1) [44]. Similar mechanisms
were described before in DCC and UNC5B expressing neurons, where
binding of NTN1 to its receptors is essential to maintain survival of
these neurons [42,43]. Under high glucose condition, NTN1 was shown
to prevent bovine aortic endothelial from high glucose induced apop-
tosis by activating ERK1/2 and eNOS [45]. The eﬀect of NTN1 on in-
creasing nitrous oxide production is discussed in Section 6.
2.3. Ligands of PLXND1 decrease endothelial cell survival via regulation of
integrin activity
The semaphorins are a large family of secreted (Class-3 sema-
phorins/SEMA3s) or membrane-associated proteins (Class- 4–7 sema-
phorins/SEMA 4–7). Almost all types of endothelial cells express high
levels of SEMA3 F. SEMA3C and SEMA3G have varied expression levels
among diﬀerent endothelial cells. SEMA3 A has moderate expression.
Class 4–7 semaphorins generally have moderate to high expression le-
vels (Fig. 3).
The main receptors of semaphorins comprise two groups, namely
neuropilins (NRP1 and NRP2) and plexins (PLXNA1-4, PLXNB1-3,
PLXNC1, and PLXND1) [46–48]. In endothelial cells, high expression
levels of PLXNA1, PLXNA2, PLXNB2 and PLXND1 can be found. NRP1
Fig. 1. Expression heatmap of netrin family proteins (left) and
their receptors (right). Values are the average normalized
expression signals from all published data on the Aﬀymetrix
Human Genome U133 Plus 2.0 Array (HG-U133 Plus 2.0/
GPL570) platform obtained using the Genevestigator software
[100]. Lighter colors indicate higher expression. Expression
levels within the top quantile on GPL570 platform are re-
cognized as “high”; levels within the inter-quantile range
(IQR) are recognized as “moderate”; levels within the bottom
quantile are recognized as “low”. These notions are used
consistently throughout this article. For comparison, we in-
clude CDH5 (VE-Cadherin) as a high-expression reference and
CDH1 (E-Cadherin) as a low-expression reference (bottom left).
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and NRP2 in general also have high expression levels. PLXNA3,
PLXNA4, PLXNB1 and PLXNB3 have moderate expression levels
(Fig. 3). Class-4–7 semaphorins can directly bind to plexins. Class-3
semaphorins, except SEMA3E, require neuropilins as obligate co-
receptors to interact with plexins, while SEMA3E can independently
bind to PLXND1 (Fig. 4). Next to SEMA3E, SEMA3C and SEMA4A are
also ligands for PLXND1 [49], and similar functional consequences
have been found when endothelial cells are stimulated with these
Fig. 2. Ligand-receptor binding map of netrin family proteins and their receptors. Red circles represent ligands, blue circles represent receptors (for interpretation of
the references to colour in this ﬁgure legend, the reader is referred to the web version of this article).
Fig. 3. Expression heatmap of semaphorin family proteins (left) and their receptors (right). Values are the average normalized expression signal from all published
data on the Aﬀymetrix Human Genome U133 Plus 2.0 Array (HG-U133 Plus 2.0/GPL570) platform obtained using the Genevestigator software [100]. Lighter colors
indicate higher expression. Expression levels within the top quantile on GPL570 platform are recognized as “high”; levels within the inter-quantile range (IQR) are
recognized as “moderate”; levels within the bottom quantile are recognized as “low”. These notions are used consistently throughout this article. For comparison, we
include CDH5 (VE-Cadherin) as a high-expression reference, and CDH1 (E-Cadherin) as a low-expression reference (bottom right).
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ligands [50,51].
Looking at a more functional level, the SEMA3E-PLXND1 axis has
been shown to be able to abrogate β1 integrin catch bonds, thus ne-
gatively regulating activity of the integrin. PLXND1 itself is required for
the normal cluster pattern of β1 integrin on cells [52]. Since PLXND1 is
widely expressed in various types of endothelial cells [50,51,53,54],
this observation is highly relevant also in endothelial cells. Sakurai
et al. [55] have established that, in immortalized mouse endothelial
cells, exogenous SEMA3E led to a decrease of β1 integrin activity and
reduced focal adhesions, as demonstrated by a decrease of paxillin
immunostaining. As a result, adhesion of these cells to collagen but not
to poly-L-lysine reduced after SEMA3E treatment. Knockdown of
PLXND1, on the other hand, almost completely abolished focal adhe-
sion with or without SEMA3E, supporting a similar role of PLXND1 in
endothelial cells on integrin patterning. Interestingly, they also found
that SEMA3E induced internalization of β1 integrin, via PLXND1-de-
pendent activation of Arf6 [55]. Together with the observations that
integrins, as mentioned before, are important stabilization and survival
signals, these mechanisms suggest that SEMA3E-PLXND1 interaction
should reduce survival signals and induce apoptosis.
Similar functional consequences were observed when endothelial
cells were treated with other ligands of PLXND1 [56]: conditioning a
medium with SEMA3C increased caspase3/7 activity of HUVECs pos-
sibly via inhibition of Akt activity; SEMA3C also decreased focal ad-
hesions and the activity of focal adhesion kinase. Soluble SEMA4A,
which is another direct ligand of PLXND1, similarly decreased adhesion
of HUVEC to ﬁbronectin and collagen IV. The eﬀect could be rescued by
activation of β1 integrin, indicating that binding of SEMA4A to PLXND1
also aﬀects integrin activity. As a result of SEMA4A/PLXND1 interac-
tion, phosphorylation of Akt was also decreased, conﬁrming the lack of
integrin activity [50]. Overall, ligands of PLXND1 are able to decrease
endothelial cell survival by interfering with integrin function and
downstream signaling.
2.4. SEMA3C promotes endothelial cell survival via integrin α5β1 and αvβ3
Using a diﬀerent mechanism, an opposite function of SEMA3C on
endothelial cells has also been observed. SEMA3C is found to be ex-
pressed in mouse glomerular endothelial cells, in which SEMA3C was
able to directly activate integrin β1, while activity of focal adhesion
kinase was not aﬀected [51]. With exogenous SEMA3C, adhesion of
mouse glomerular endothelial cells to collagen and ﬁbronectin could be
increased, but not to gelatin [51]. Indeed, blocking antibody against
α5β1 and αvβ3 integrin blocked the increase of adhesion to ﬁbronectin
induced by SEMA3C [51]. This is consistent with the fact that ﬁ-
bronectin is a Arg-Gly-Asp-containing ligand, to which α5β1 and αvβ3
integrins can bind [57]. The diﬀerence in the extracellular matrix
coating is one possible explanation why an opposite role of SEMA3C
was seen here. In a similar experiment using only gelatin coating, no
pro-survival function could be detected [56].
3. Role of netrins and semaphorins in the renewal potential of
endothelial cells
The second phase in endothelial cell turnover is to replace the da-
maged endothelium with healthy endothelial cells, which requires en-
dothelial renewal capability. This ability is often assessed in vitro with
proliferation assays and/or wound-healing assays, mimicking the en-
dothelial self-renewal and repairing capability, respectively. To be
noted is that the mechanisms underlying the renewal potential are
sometimes similar to what we have discussed in Section 2 for en-
dothelial survival, resulting from versatile pathways regulating both
functions. In addition, interpretation of proliferative capability should
be done with caution, since quiescent endothelial cells do not pro-
liferate but make up the actual functional endothelium in stable vas-
culature.
Fig. 4. The ligand-receptor binding map of semaphorin family proteins and their receptors. Red circles represent ligands, blue circles represent receptors (for
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article).
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3.1. NTN1 dose-dependently aﬀects endothelial cell renewal
in vitro studies demonstrated that lower concentrations of NTN1
(∼100 ng/ml) promote proliferation of endothelial cells [58–62], while
an extremely high concentration of NTN1 inhibits [60,59–62] or has no
eﬀect [63] on the proliferation of endothelial cells. Considering that the
typical concentration of NTN1 in human plasma is only several pico-
grams to several hundred picograms per milliliter NTN1 [33], the
physiological concentration in plasma is far from reaching the threshold
for an inhibitory eﬀect on proliferation. NTN1 has been found to play
dual roles on the wound-healing capacity of endothelial cells. A low
concentration of NTN1 increased the rate with which the gap in a
monolayer of endothelial cells was closed in culture [64–67], while a
high concentration of NTN1 decreased that [65]. Multiple studies
conﬁrmed that the canonical receptor of NTN1, UNC5B, mediated the
inhibitory eﬀect of NTN1, since siRNA knockdown of UNC5B abolished
this inhibitory eﬀect [60,62]. Interestingly, UNC5B-knockout mice
displayed excessive development of blood vessels, while the same
phenotype was not observed in NTN1-knockout mouse, further con-
ﬁrming that NTN1 in physiological concentrations does not primarily
regulate the downstream signaling of UNC5B [64,68]. In 2015, Tu et al.
[62] identiﬁed the melanoma cell adhesion molecule (MCAM) or
CD146 as a novel NTN1 receptor that could mediate the stimulatory
eﬀect of NTN1 on proliferation. MCAM co-immunoprecipitated with
NTN1 in endothelial cells and had a better binding aﬃnity compared to
UNC5B (dissociation constant Kd= 1.33 nM vs 5.10 nM), which is
consistent with the ﬁnding that MCAM is responsible for NTN1 function
in lower concentration ranges. Blocking MCAM expression using siRNA
indeed abolished the eﬀect of NTN1 on the proliferation of endothelial
cells [62]. Therefore, the NTN1/MCAM pathway most likely mediates
the stimulatory eﬀect of (low levels of) NTN1 on proliferation, while
UNC5B mediates the NTN1-induced decrease in proliferation when
high levels of NTN1 are present.
3.2. The eﬀect of NTN4 on endothelial cell renewal is ambiguous
The eﬀect of NTN4 on the endothelial cell renewal capacity is still a
matter of on-going debate. Wilson et al. [59] found that NTN4, similar
to NTN1, promoted proliferation of various types of endothelial cells at
lower concentrations. For very high concentrations of NTN4, Nacht
et al. [20] found an inhibitory eﬀect of NTN4 on the proliferation of
HMVECs. In contrast to NTN1, Dakouane-Giudicelli et al. [69] showed
that a lower concentration of NTN4 also had an inhibitory eﬀect on
both proliferation and wound-healing capacity of human placenta en-
dothelial cells. It is very likely that diﬀerent mechanisms are involved
in the eﬀect of NTN4 on endothelial cells, as both structural biology
analysis and kinetic binding analysis revealed that NTN4 is not able to
bind to several canonical receptors of netrin family, namely DCC,
Neogenin and UNC5B [32]. Instead, NTN4 could bind to laminin γ
chain to regulate laminin network formation and, potentially, stiﬀness
of the endothelial basement membrane [32]. Since stiﬀness of extra-
cellular matrix also has an inﬂuence on endothelial cell function, more
investigation is needed to fully understand the mechanism of NTN4 and
its eﬀect on endothelial cell proliferation [70].
3.3. SEMA3 family members have dual roles in endothelial cell proliferation
Multiple mechanisms have been proposed to explain the involve-
ment of SEMA3 family members in proliferation of endothelial cells.
Class-3 semaphorins except SEMA3E share neuropilins as co-receptor
with the VEGF165 isoform, although evidences showed that VEGF121
isoform can also bind NRP. Neuropillins serve to augment downstream
signaling of VEGF165 in endothelial cells by forming a receptor com-
plex with VEGFR2 [71,72]. Survival signaling by VEGF is especially
important during development but can still be of signiﬁcance in a sta-
bilized vascular network [73]. Loss of VEGF signaling after
development decreases vascular integrity, causing symptoms like brain
hemorrhage and heart ﬁbrosis in endothelial conditional VEGF-
knockout mice [73]. Because of the competition for NRPs between
VEGF and SEMA3s, SEMA3s were found to be endogenous inhibitors of
VEGF [74–76]. SEMA3A, SEMA3B, SEMA3C and SEMA3F can all re-
duce endothelial proliferation in the presence of VEGF, which can be
blocked by NRP antibody or silencing NRP [56,77–80]. SEMA3E, on the
other hand, binds directly to PLXND1 and the binding of SEMA3E and
PLXND1 could also cause upregulation of soluble VEGFR1 in en-
dothelial cells, which serves as endogenous VEGF decoy [81]. Similar to
its eﬀect on survival of endothelial cells, SEMA3C plays dual roles on
endothelial cell proliferation as well. The increase of proliferation and
decrease of apoptosis was attributed to the ability of SEMA3C to induce
activation of integrin β1 [51]. This eﬀect could be blocked by NRP1
antibodies, conﬁrming the necessity of NRP1 as a co-receptor of
SEMA3C [51].
4. Roles of netrins and semaphorins in the response to vessel wall
shear stress
Endothelial cells sense shear stress via mechanosensors and trigger a
variety of downstream signals that are necessary for the survival of
endothelial cells after initial angiogenic stimuli. Unidirectional laminar
wall shear stress is a critical hemodynamic factor for endothelial cell
maturation and quiescence. An unfavorable hemodynamic environment
can disturb quiescent signaling and lead to endothelial cell activation
and inﬂammation, often leading to the development of atherosclerotic
lesions. Several studies have proposed roles for neuronal guidance cues
as mediators of eﬀects of shear stress.
4.1. NTN1 and SEMA3A repel leukocytes in response to laminar shear
stress
Expression of both netrins and semaphorins is regulated by wall
shear stress. In LDL receptor knockout mice, lower expression of NTN1
could be detected in the inner curvature of the aorta compared to the
outer curvature [34]. Given that the endothelium in the inner curvature
of mouse aorta experiences lower wall shear stress than in the outer
curvature, NTN1 is positively regulated by shear stress. This regulation
was conﬁrmed in vitro using human coronary artery endothelial cells
cultured under unidirectional laminar ﬂow [34]. In addition, NTN1 was
shown to have a repellent role on both migration and adhesion of
leukocytes [18,34,35,82]. Neutralizing NTN1 using a blocking antibody
abolished the inhibitory eﬀect of NTN1 on leukocyte adhesion to en-
dothelial cells both in vitro and in cremaster capillaries in mice [34].
UNC5B, the receptor of NTN1 involved in its inhibitory proliferative
eﬀects, is expressed in peripheral blood leukocytes [35]. Blocking
UNC5B using an inhibitory antibody abolished the eﬀect of NTN1 on
monocyte migration, conﬁrming the canonical NTN1-UNC5B pathway
as the underlying mechanism for the inhibition of leukocyte adhesion
and migration [34]. As we discussed above, NTN1 also has a pro-sur-
vival function for endothelial cells under physiological concentrations.
These observations suggest that NTN1 is one of the mediators for the
adaptation of endothelial cells to their hemodynamic environment, to
promote survival of endothelial cells, and to inhibit leukocyte adhesion
to quiescent endothelium under laminar shear stress.
Similar regulation of expression by wall shear stress applies to
SEMA3A. Higher expression of SEMA3A was found both in the outer
curvature of the aorta of LDL receptor knockout mice and in human
coronary artery endothelial cells cultured under laminar ﬂow. SEMA3A
also inhibits adhesion of RAW264.7 cells (a macrophage-like cell line)
and transwell migration of THP-1 cells (a monocyte-like cell line) in
vitro. In addition, a blocking peptide of SEMA3A increases leukocyte
adhesion to endothelium in cremaster capillaries [34]. These observa-
tions implicate SEMA3A as another mediator for the adaptation of en-
dothelial cells to their hemodynamic environment. However, the
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mechanism how SEMA3A has this eﬀect needs to be further elucidated.
4.2. SEMA7A enhances atherosclerosis in response to disturbed blood ﬂow
In contrast to NTN1 and SEMA3A, SEMA7A is upregulated in the
left carotid artery of ApoE -/- mice upon disturbed ﬂow induced by a
partial carotid artery ligation procedure [83]. This positive regulation
was conﬁrmed by the elevated expression of SEMA7A in HUVECs cul-
tured under oscillatory shear stress. The upregulation was mediated by
downregulation of CREB phosphorylation, while CREB is known as a
downstream eﬀector of laminar shear stress. The disturbed ﬂow in the
left carotid artery of ApoE -/- mice with partial ligation promoted
atherogenesis in this region, but much less atherosclerotic lesions could
be seen in the same region in ApoE -/- SEMA7A -/- double knockout
mice. Further studies found that SEMA7A overexpressing HUVECs also
expressed more ICAM and VCAM, and allowed more monocyte adhe-
sion [83]. The reason for such changes is yet to be determined, but
these observations make SEMA7A a possible mediator of the eﬀects of
adverse hemodynamic environment on endothelial cells and even ren-
ders it a potential therapeutic target.
4.3. Downregulation of SEMA6A/6D by shear stress induced miR-27b
promote pericyte recruitment
In the case of SEMA6A and SEMA6D, shear stress regulates their
expression indirectly via upregulation of microRNA miR-27b.
Downregulation of SEMA6A and SEMA6D by such mechanism in
HUVECs was found to increase adhesion of human brain vascular
pericytes to HUVECs. Inhibition of miR-27b in mice by in-
traperitoneally injection of locked nucleic acid reduce pericyte to en-
dothelial ratio in the uterus. Since pericyte recruitment is a key step in
vascular maturation, these experiments provide one of the mechanisms
how semaphorins are regulated downstream of shear stress via
microRNAs to allow endothelium-pericytes interaction [84].
5. Roles of netrins and semaphorins in the endothelial barrier
function
Vascular endothelium provides a crucial selective barrier for mo-
lecule exchange between blood and tissue ﬂuid and for controlled blood
cell inﬁltration. A well-maintained endothelial barrier function relies
on correct cytoskeleton arrangements and formation of endothelial cell-
cell junctions. Quiescent endothelial cells have abundant cortical ﬁla-
mentous actin (F-actin) network and few stress ﬁbers. Such a cytoske-
letal structure limits centripetal tension in endothelial cells and keeps
them in a spread morphology. The intercellular connections of en-
dothelial cells are made possible by the formation of both tight junc-
tions and adherens junctions. On the molecular level, tight junctions
and adherens junctions ‘seal’ adjacent endothelial cells by a hemophilic
interaction of claudin and occludin proteins, and vascular endothelial
cadherin (VE-cadherin or CDH5) proteins, respectively. The cyto-
plasmic tails of CDH5 interact with several intracellular components
resulting in actin ﬁlament binding. Factors that have inﬂuence on either
cytoskeletal networks or directly on endothelial cell-cell junctions can
alter the endothelial barrier function. Through these mechanisms, ne-
trins and semaphorins are identiﬁed as regulators of the barrier func-
tion of the endothelium.
5.1. NTN1 is necessary for tight junctions in the blood-brain barrier
Intact tight junctions are critical in the blood-brain barrier to ensure
more selective exchange of molecules between cerebrospinal ﬂuid and
blood. Neonatal mice with a NTN1 knockout genotype displayed im-
paired function of the blood-brain barrier, as the permeability for
macromolecules increased [19]. The eﬀect was due to disrupted tight
junctions, as evidenced by a decrease of occludin and JAM-A (tight
junction proteins) expression that was observed in the endothelium of
brain blood vessels of NTN1 knockout mice [19]. It is possible that
NTN1 in wild type conditions is presented to endothelial cells by as-
trocytes in the brain, since conditioned medium from astrocytes, similar
to recombinant NTN1, upregulates several tight junction components
including ZO-1, p120 and α-catenin in human brain-derived endothelial
cells [19,85]. The therapeutic potential of NTN1 has been examined in
experimental autoimmune encephalomyelitis and middle cerebral ar-
tery occlusion models [19,86]. In both cases, mice treated with NTN1
showed improved barrier function of the blood-brain barrier [19,86].
However, the exact mechanism on how NTN1 contributes to formation
or maintenance of the tight junctions is not known yet. It is interesting
to note that MCAM is part of the endothelial cell-cell junction alongside
tight junctions and adherent junctions [87]. Previously, we discussed
the involvement of MCAM as a receptor for NTN1 in endothelial cell
survival. Whether the NTN1/MCAM signaling pathway can play a role
in endothelial junction formation remains an interesting topic for future
research.
5.2. SEMA3A induces endothelial permeability
Multiple studies demonstrated SEMA3A as a factor inducing per-
meability [88–91]. Injection of SEMA3A led to increased vessel per-
meability in mouse retro-orbital venous sinus [88], mouse ear vessels
[89], mouse retina [90], and mouse subcutaneous capillaries [91]. This
eﬀect was conﬁrmed in vitro with human brain endothelial cells [88],
rat brain capillary endothelial cells [89], and HUVECs [90,91]. Increase
in phosphorylation of CDH5 was observed in endothelial cells after
SEMA3A treatment, resulting in internalization of CDH5 and destabi-
lization of adherent junctions [88,90,91]. The eﬀects were dependent
on NRP1 expressed by endothelial cells [90,91]. As one of the under-
lying mechanisms, Le Guelte et al. [88] suggested that SEMA3A/NRP1/
PLXNA2 signaling leads to phosphorylation of Src kinase, which causes
dissociation of PP2A from CDH5, thereby exposing a phosphorylation
site on CDH5. SEMA3A has also been found to increase association of
VEGFR1 to Mical2, with Mical2 being an enhancer of F-actin depoly-
merization [89]. Indeed, SEMA3A was found to induce a collapse in F-
actin ﬁbers [54,80]. In addition, in SEMA3A-knockout mice ischemia-
reperfusion in the brain caused less leakage from brain blood vessels
compared to wild-type mice [89]. Altogether this implies that SEMA3 A
increase endothelial permeability by disrupting adherens junction and
collapsing cytoskeleton. However, controversy remains on the source of
SEMA3A as endothelial cells express signiﬁcant but low levels of
SEMA3A and endothelial cell-speciﬁc knockout of SEMA3A did not
cause a change in permeability of skin vessels [92].
6. Role of netrin-1 in controlling of the vascular tone
One of the important functions of endothelial cells is to control
vascular tone. This function is realized by production of both vasodi-
lators and vasoconstrictors by endothelial cells. Nitric oxide (NO), a
soluble gas, is an important endogenous vasodilator. Besides vasodila-
tion, NO also serves as an anti-inﬂammatory and anti-oxidative factor
for endothelial cells (see the review by Tousoulis et al. [93]). Limited
data is available to elucidate the role of NGCs in the regulation of
vascular tone. To our knowledge, no role for semaphorins in controlling
vascular tone has been described. For the netrins however, an inter-
esting role for NTN1 in this process is described in several studies.
6.1. NTN1 controls vascular tone by stimulating release of nitric oxide via
DCC receptors
In 2006, Nguyen and Cai [67] found that NTN1 increased activity of
endothelial nitric oxide synthase (eNOS) via phosphorylation of extra-
cellular signal-regulated kinase (ERK1/2). Phosphorylation of ERK1/2
led to an increased activity of eNOS, which then catalyzed the oxidation
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of L-arginine to produce NO [67,94]. This eﬀect could be blocked by a
DCC antibody, suggesting involvement of DCC as the responsible re-
ceptor [45,67,95–97]. Despite low expression of DCC on endothelial
cells, it was shown that NO itself preserves DCC from degradation in
endothelial cells via inhibition of the E3 ubiquitin ligase “seven in ab-
sentia homolog” (SIAH) [98]. The ability of NTN1 to activate NO pro-
duction gives it a protective function in organ ischemia reperfusion.
Infusion of NTN1 following ischemia reperfusion of mouse hearts de-
creases infarct size and improves mitochondrial dysfunction, resulting
from the increased bio-availability of NO [96,97,99]. Very recently,
induction of NO production by NTN1 was conﬁrmed in vivo in NTN1
transgenic mice. Compared to WT mice, NTN1 transgenic mice showed
increased level of NO in aortic ring assessed by 4,5-diaminoﬂuorescein
(DAF-2) staining. Under normal condition, response of aortas to acet-
ylcholine (relaxation), nitroprusside (relaxation) and phenylephrine
(contraction) did not change by NTN1 transgene. In diabetic condition,
NTN1 overexpression transgene could protect the mice from dampened
response to relaxation agents and exaggerated response to contraction
agent. [45]
7. Concluding remarks
In this review, we summarized relevant studies about the involve-
ment of netrins (Fig. 5) and semaphorins (Fig. 6) in the function of
mature endothelial cells. Netrins and semaphorins were originally
identiﬁed to have axonal guidance function in the nervous system.
Given the striking similarity in anatomy of the peripheral nervous and
vascular systems, it is not surprising that the vascular system uses the
same group of molecules in development. A lesson learned in recent
years is that the function of mature and quiescent endothelial cells is of
great importance and requires active regulation. Besides other well-
known mechanisms, evidence accumulates suggesting that netrins and
semaphorins continue to serve as intercellular and extracellular cues for
endothelial cells to maintain their quiescent state and related functions
as described in this review. These functions also give both netrins and
semaphorins implications in the development of several diseases. De-
spite the fact that more and more attention is being paid to the reg-
ulation of endothelial cell function by NGCs, most research has been
performed in vitro.More in vivo evidence is required to fully conﬁrm the
Fig. 5. Schematic representation of mature endothelial cell biology, indicating the roles of netrin family proteins.
1. Moderate secretion of NTN1.
2. Saturated concentration of NTN1.
3. High aﬃnity binding.
4. Basolateral secretion.
5. Activation of integrin α6β1.
6. Physiological concentration of NTN4 possibly changes the stiﬀness of the laminin matrix.
7. Saturating concentration of NTN4 dissociates the laminin network.
8. Low stiﬀness of extracellular matrix promotes endothelial cell quiescence.
9. NTN1 is necessary for tight junction stability in the blood-brain barrier.
10. NTN1 binds to MCAM; this could have an inﬂuence on endothelial barrier.
11. Laminar shear stress increases the expression of NTN1, while disturbed ﬂow decreases it.
12. NTN1 increases NO production via DCC receptors and ERK1/2. In addition, NO protects DCC from degradation through inhibition of E3 ubiquitin ligase SIAH.
H. Zhang et al. Pharmacological Research 137 (2018) 1–10
7
necessity of semaphorins and netrins. As research into this aspect is
ongoing, we expect new insights in the near future. For example, it has
already been shown that NTN1 promotes endothelial tight junctions in
the blood-brain barrier in a model of experimental autoimmune en-
cephalomyelitis (which is a mouse model for brain inﬂammation caused
by loss of blood-brain barrier function) and middle cerebral artery oc-
clusion models (mouse models for stroke). Moreover, SEMA7A can
elevate monocyte adhesion in regions with disturbed ﬂow and thereby
promote atherosclerosis. Taken together, NGCs are intrinsically in-
volved in endothelial physiology and pathophysiology. Further under-
standing their roles can be of relevance for vascular diseases. For in-
stance the role of NGCs in leukocyte recruitment and endothelial
barrier function would be of relevance in atherosclerosis and vasculitis.
While their role on endothelial-pericyte interaction are of vast im-
portance in nephropathy. Further investigations of NGCs could reveal
novel disease targets towards sustaining vascular health and integrity.
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